{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T17:39:30Z","timestamp":1767980370703,"version":"3.49.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.1016\/j.neulet.2007.08.013","type":"journal-article","created":{"date-parts":[[2007,8,14]],"date-time":"2007-08-14T11:23:36Z","timestamp":1187090616000},"page":"28-33","source":"Crossref","is-referenced-by-count":11,"title":["Poly(ADP-ribose) polymerase-1 is involved in the neuronal death induced by quinolinic acid in rats"],"prefix":"10.1016","volume":"425","author":[{"given":"Perla Deyanira","family":"Maldonado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Elena","family":"Ch\u00e1nez-C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Barrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juana","family":"Villeda-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abel","family":"Santamar\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Pedraza-Chaverr\u00ed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2007.08.013_bib1","first-page":"255","article-title":"Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke","volume":"7","author":"Abdelkarim","year":"2001","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neulet.2007.08.013_bib2","doi-asserted-by":"crossref","first-page":"18308","DOI":"10.1073\/pnas.0606526103","article-title":"Poly(ADP-ribose) (PAR) polymer is a death signal","volume":"103","author":"Andrabi","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.neulet.2007.08.013_bib3","doi-asserted-by":"crossref","first-page":"H2972","DOI":"10.1152\/ajpheart.01039.2004","article-title":"Poly(ADP ribose) polymerase inhibitor PJ-34 reduces mesenteric vascular injury induced by experimental cardiopulmonary bypass with cardiac arrest","volume":"288","author":"Andrasi","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.neulet.2007.08.013_bib4","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/S0021-9258(18)45983-2","article-title":"Specific inhibitors of poly(ADP-ribose) synthetase and mono(ADP-ribosyl)transferase","volume":"267","author":"Banasik","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2007.08.013_bib5","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/jnr.1244","article-title":"NMDA receptor function in mouse models of Huntington disease","volume":"66","author":"Cepeda","year":"2001","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.neulet.2007.08.013_bib6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0165-5728(01)00418-0","article-title":"Synthesis and release of neurotoxic kynurenine metabolites by human monocyte-derived macrophages","volume":"120","author":"Chiarugi","year":"2001","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.neulet.2007.08.013_bib7","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1046\/j.1471-4159.2001.00335.x","article-title":"Similarities and differences in the neuronal death processes activated by 3OH-kynurenine and quinolinic acid","volume":"77","author":"Chiarugi","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2007.08.013_bib8","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/nm1097-1089","article-title":"Poly (ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischemia","volume":"10","author":"Eliasson","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.neulet.2007.08.013_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0003-4975(01)03329-X","article-title":"Myocardial protection by PJ34, a novel potent poly(ADP-ribose) synthetase inhibitor","volume":"73","author":"Faro","year":"2002","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.neulet.2007.08.013_bib10","doi-asserted-by":"crossref","first-page":"3061","DOI":"10.1007\/s00018-006-6345-7","article-title":"Protective effects of the PARP-1 inhibitor PJ34 in hypoxic-reoxygenated cardiomyoblasts","volume":"63","author":"Fiorillo","year":"2006","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.neulet.2007.08.013_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.phrs.2005.02.013","article-title":"Clinical perspectives of PARP inhibitors","volume":"52","author":"Graziani","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.neulet.2007.08.013_bib12","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1111\/j.1471-4159.2004.02547.x","article-title":"PARP-1 gene disruption in mice preferentially protects males from perinatal brain injury","volume":"90","author":"Hagberg","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2007.08.013_bib13","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1007\/s00018-002-8527-2","article-title":"The functional role of poly(ADPribose) polymerase 1 as novel coactivator of NF-kappaB in inflammatory disorders","volume":"59","author":"Hassa","year":"2002","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.neulet.2007.08.013_bib14","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nrd1718","article-title":"Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors","volume":"4","author":"Jagtap","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neulet.2007.08.013_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.nbd.2003.09.003","article-title":"Excitotoxic degeneration of hypothalamic orexin neurons in slice culture","volume":"15","author":"Katsuki","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2007.08.013_bib16","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1164\/ajrccm.165.3.2106050","article-title":"Activation of poly(ADP-ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation","volume":"165","author":"Liaudet","year":"2002","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.neulet.2007.08.013_bib17","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/labinvest.3700326","article-title":"Inhibition of poly(ADP-ribose) polymerase attenuates the severity of acute pancreatitis and associated lung injury","volume":"85","author":"Mota","year":"2005","journal-title":"Lab. Invest."},{"key":"10.1016\/j.neulet.2007.08.013_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.neuroscience.2005.06.027","article-title":"Excitotoxic brain damage involves early peroxynitrite formation in a model of Huntington's disease in rats: protective role of iron porphyrinate 5,10,15,20-tetrakis (4-sulfonatophenyl)porphyrinate iron(III)","volume":"135","author":"Perez-De La Cruz","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2007.08.013_bib19","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.neuint.2004.06.008","article-title":"S-allylcysteine, a garlic-derived antioxidant, ameliorates quinolinic acid-induced neurotoxicity and oxidative damage in rats","volume":"45","author":"Perez-Severiano","year":"2004","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neulet.2007.08.013_bib20","doi-asserted-by":"crossref","first-page":"H1545","DOI":"10.1152\/ajpheart.01124.2005","article-title":"Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy","volume":"291","author":"Pillai","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.neulet.2007.08.013_bib21","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S0006-8993(99)02474-9","article-title":"Effect of quinolinic acid on endogenous antioxidants in rat corpus striatum","volume":"858","author":"Rodriguez-Martinez","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2007.08.013_bib22","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.nbd.2005.04.010","article-title":"Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat","volume":"20","author":"Ryu","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2007.08.013_bib23","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1097\/00001756-200108280-00020","article-title":"In vivo hydroxyl radical formation alter quinolinic acid infusion into rat corpus striatum","volume":"12","author":"Santamaria","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.neulet.2007.08.013_bib24","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.6849138","article-title":"Quinolinic acid: an endogenous metabolite that produces axon-sparing lesions in rat brain","volume":"219","author":"Schwarcz","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.neulet.2007.08.013_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.coph.2003.10.006","article-title":"The kynurenine pathway of tryptophan degradation as a drug target","volume":"4","author":"Schwarcz","year":"2004","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neulet.2007.08.013_bib26","first-page":"309","article-title":"Neuropharmacology of quinolinic and kynurenic acids","volume":"45","author":"Stone","year":"1993","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neulet.2007.08.013_bib27","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1124\/pr.54.3.375","article-title":"The therapeutic potential of poly(ADP-ribose) polymerase inhibitors","volume":"54","author":"Virag","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neulet.2007.08.013_bib28","doi-asserted-by":"crossref","first-page":"F387","DOI":"10.1152\/ajprenal.00436.2003","article-title":"Poly(ADP-ribose) polymerase-1 gene ablation protects mice from ischemic renal injury","volume":"288","author":"Zheng","year":"2005","journal-title":"Am. J. Physiol. Renal. Physiol."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394007008488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394007008488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T18:29:20Z","timestamp":1629570560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394007008488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S0304394007008488"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2007.08.013","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}